US-based, AI-native platform Doctronic has secured $20m in a Series A funding round to provide affordable and personalised healthcare.

The round was led by Lightspeed Venture Partners, with contributions from Tusk Ventures, Union Square Ventures, Seven Stars, Mantis VC, and individual investors, such as Scott Belsky, Dr Fei-Fei Li, and Jay Desai.

Lightspeed Venture partner Faraz Fatemi said: “Doctronic is scaling at a pace that makes it clear the future of healthcare will be AI-driven. What sets them apart is far more than just speed or convenience, but a fundamentally unique agentic architecture that pairs collective AI intelligence with real clinical oversight.

“That combination makes Doctronic the trusted front door for millions of patients and positions them to define what next-gen healthcare looks like in America.”

Doctronic was established by Dr Adam Oskowitz and Matt Pavelle and seeks to solve ongoing issues relating to quicker access to quality healthcare by integrating generative AI.

The platform provides personalised, anonymous health advice within minutes and links users to licensed doctors through video consultations, usually for less than the cost of a standard co-payment.

Users can access Doctronic’s AI advisor at no cost, receiving four possible explanations for their symptoms, an assessment based on likelihood, and an AI-generated plan that includes a SOAP note for healthcare providers.

The platform manages over 50,000 visits each week and has facilitated more than 15 million medical interactions with one million users.

Doctronic has commenced collaborations with insurers and healthcare systems, including a programme with Safe Harbour Health aimed at reaching over 100,000 patients.

Last month, it published results demonstrating that its autonomous AI doctor achieved a 99.2% alignment in treatment decisions with licensed clinicians.